Literature DB >> 33469151

LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes.

Carl Herdenberg1, Pascal M Mutie2, Ola Billing3, Ahmad Abdullah1, Rona J Strawbridge4,5,6, Ingrid Dahlman7, Simon Tuck8, Camilla Holmlund1, Peter Arner7, Roger Henriksson1, Paul W Franks2, Håkan Hedman9.   

Abstract

Leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins have been implicated as regulators of growth factor signaling; however, the possible redundancy among mammalian LRIG1, LRIG2, and LRIG3 has hindered detailed elucidation of their physiological functions. Here, we show that Lrig-null mouse embryonic fibroblasts (MEFs) are deficient in adipogenesis and bone morphogenetic protein (BMP) signaling. In contrast, transforming growth factor-beta (TGF-β) and receptor tyrosine kinase (RTK) signaling appeared unaltered in Lrig-null cells. The BMP signaling defect was rescued by ectopic expression of LRIG1 or LRIG3 but not by expression of LRIG2. Caenorhabditis elegans with mutant LRIG/sma-10 variants also exhibited a lipid storage defect. Human LRIG1 variants were strongly associated with increased body mass index (BMI) yet protected against type 2 diabetes; these effects were likely mediated by altered adipocyte morphology. These results demonstrate that LRIG proteins function as evolutionarily conserved regulators of lipid metabolism and BMP signaling and have implications for human disease.

Entities:  

Year:  2021        PMID: 33469151      PMCID: PMC7815736          DOI: 10.1038/s42003-020-01613-w

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  76 in total

1.  LRIG1 protein in human cells and tissues.

Authors:  Jonas Nilsson; Anna Starefeldt; Roger Henriksson; Håkan Hedman
Journal:  Cell Tissue Res       Date:  2003-03-18       Impact factor: 5.249

2.  Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia.

Authors:  Yutaka Suzuki; Hiroyuki Miura; Atsushi Tanemura; Kinji Kobayashi; Gen Kondoh; Shigetoshi Sano; Kentaro Ozawa; Shigeki Inui; Aya Nakata; Tsutomu Takagi; Masaya Tohyama; Kunihiko Yoshikawa; Satoshi Itami
Journal:  FEBS Lett       Date:  2002-06-19       Impact factor: 4.124

3.  Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue.

Authors:  Hui Gao; Niklas Mejhert; Jackie A Fretz; Erik Arner; Silvia Lorente-Cebrián; Anna Ehrlund; Karin Dahlman-Wright; Xiaowei Gong; Staffan Strömblad; Iyadh Douagi; Jurga Laurencikiene; Ingrid Dahlman; Carsten O Daub; Mikael Rydén; Mark C Horowitz; Peter Arner
Journal:  Cell Metab       Date:  2014-05-22       Impact factor: 27.287

Review 4.  Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure.

Authors:  Nader Zamani; Chester W Brown
Journal:  Endocr Rev       Date:  2010-12-20       Impact factor: 19.871

5.  The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor.

Authors:  Anne E Powell; Yang Wang; Yina Li; Emily J Poulin; Anna L Means; Mary K Washington; James N Higginbotham; Alwin Juchheim; Nripesh Prasad; Shawn E Levy; Yan Guo; Yu Shyr; Bruce J Aronow; Kevin M Haigis; Jeffrey L Franklin; Robert J Coffey
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

6.  Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis.

Authors:  Aaron Broege; Lan Pham; Eric D Jensen; Ann Emery; Tsang-Hai Huang; Melissa Stemig; Hideyuki Beppu; Anna Petryk; Michael O'Connor; Kim Mansky; Raj Gopalakrishnan
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

7.  The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea.

Authors:  Dongsheng Guo; Camilla Holmlund; Roger Henriksson; Håkan Hedman
Journal:  Genomics       Date:  2004-07       Impact factor: 5.736

8.  Cross-repressive interactions between Lrig3 and netrin 1 shape the architecture of the inner ear.

Authors:  Victoria E Abraira; Tony Del Rio; Andrew F Tucker; John Slonimsky; Hannah L Keirnes; Lisa V Goodrich
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

9.  Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling.

Authors:  Vivian W Y Wong; Daniel E Stange; Mahalia E Page; Simon Buczacki; Agnieszka Wabik; Satoshi Itami; Marc van de Wetering; Richard Poulsom; Nicholas A Wright; Matthew W B Trotter; Fiona M Watt; Doug J Winton; Hans Clevers; Kim B Jensen
Journal:  Nat Cell Biol       Date:  2012-03-04       Impact factor: 28.824

10.  A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors.

Authors:  Mahmood Faraz; Carl Herdenberg; Camilla Holmlund; Roger Henriksson; Håkan Hedman
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

View more
  4 in total

Review 1.  HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?

Authors:  Carl Herdenberg; Håkan Hedman
Journal:  Stem Cell Rev Rep       Date:  2022-08-15       Impact factor: 6.692

2.  Netrin-1 functions as a suppressor of bone morphogenetic protein (BMP) signaling.

Authors:  Ahmad Abdullah; Carl Herdenberg; Håkan Hedman
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

3.  Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus.

Authors:  Ji Min Kim; Kyong Hye Joung; Jun Choul Lee; Sorim Choung; Seon Mee Kang; Hyun Jin Kim; Bon Jeong Ku
Journal:  Ann Transl Med       Date:  2021-11

4.  Identification of genetic effects underlying type 2 diabetes in South Asian and European populations.

Authors:  Marie Loh; Weihua Zhang; Jaspal S Kooner; Danish Saleheen; John C Chambers; Hong Kiat Ng; Katharina Schmid; Amel Lamri; Lin Tong; Meraj Ahmad; Jung-Jin Lee; Maggie C Y Ng; Lauren E Petty; Cassandra N Spracklen; Fumihiko Takeuchi; Md Tariqul Islam; Farzana Jasmine; Anuradhani Kasturiratne; Muhammad Kibriya; Karen L Mohlke; Guillaume Paré; Gauri Prasad; Mohammad Shahriar; Miao Ling Chee; H Janaka de Silva; James C Engert; Hertzel C Gerstein; K Radha Mani; Charumathi Sabanayagam; Marijana Vujkovic; Ananda R Wickremasinghe; Tien Yin Wong; Chittaranjan S Yajnik; Salim Yusuf; Habibul Ahsan; Dwaipayan Bharadwaj; Sonia S Anand; Jennifer E Below; Michael Boehnke; Donald W Bowden; Giriraj R Chandak; Ching-Yu Cheng; Norihiro Kato; Anubha Mahajan; Xueling Sim; Mark I McCarthy; Andrew P Morris
Journal:  Commun Biol       Date:  2022-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.